Lekarze w leczeniu Fibroma desmoides za granicą — Strona 2

Specjalizując się w wiroterapii — nowoczesnej metodzie immunologicznej — dr Jaunalksne wnosi ponad 30-letnie doświadczenie w leczeniu włókniaków powięziowych (guzów desmoidalnych).

• Kieruje Centrum Immunologii Klinicznej w Szpitalu Uniwersyteckim im. Paulsa Stradiņša
• Absolwentka Ryskiego Instytutu Medycznego, ukończyła staż w zakresie chorób wewnętrznych
• Koncentruje się na innowacyjnych metodach leczenia immunologicznego

Specjalizuje się w leczeniu włókniaków powięziowych (guzów desmoidalnych). Odbył intensywne szkolenie w zakresie onkologii klinicznej na Uniwersytecie Akdeniz.

• Posiada certyfikat specjalisty w dziedzinie onkologii klinicznej
• Pracuje w kompleksie szpitalnym Medical Park Antalya
• Jest członkiem Tureckiego Towarzystwa Onkologii Klinicznej

Dr Muzaffer Al specjalizuje się w chirurgii laparoskopowej i onkologicznej w szpitalach Büyük Anadolu. Posiada zaawansowane przeszkolenie w zakresie technik małoinwazyjnych.

• Certyfikowany specjalista chirurgii ogólnej z ponad 20-letnim doświadczeniem
• Specjalizuje się w laparoskopowej chirurgii antyrefluksowej i bariatrycznej
• Przeszkolony w zakresie chirurgii onkologicznej na Uniwersytecie Stambulskim

Dr. Liu Shi Xin is the Vice Chairman of the Radiation Oncology Branch of the Chinese Medical Association. He serves as the Discipline Leader of the Oncology Center at Xiamen Humanity Hospital. Dr. Liu specializes in precision radiotherapy for thoracic and abdominal cancers. He is a recipient of the State Council Special Government Allowance for his medical contributions.

• Highly proficient in IMRT, VMAT, and SBRT for lung and esophageal cancers.
• Former President of Jilin Provincial Cancer Hospital.
• Awarded the National Famous Doctor honor for outstanding contributions to oncology.
• Holds leadership roles in the Chinese Anti-Cancer Association particle therapy committee.

Dr. Ayşe İrem Yasin is a medical oncologist at Medipol Acıbadem District Hospital in Istanbul. She holds a prestigious ESMO Board Certificate. Dr. Yasin specializes in solid tumors, including breast, lung, and gastrointestinal cancers. She treats complex cases such as Merkel cell carcinoma and cancers of unknown primary.

• Trained at Harvard Medical School, Cleveland Clinic, and Basel University Hospital.
• Completed a clinical observership at the Breast Cancer Unit in Novara, Italy.
• Treats brain and CNS malignancies, soft tissue sarcomas, and urologic cancers.
• Works at a JCI-accredited facility equipped with the da Vinci robotic system.

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at Liv Hospital Topkapı. He specializes in treating colon, breast, gastric, and lung cancers. He previously served as the Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital. Dr. Atci is a member of the American Society of Clinical Oncology (ASCO).

• Author of 19 peer-reviewed papers on gastrointestinal, thoracic, and endocrine cancers.
• Published studies on survival outcomes for stage IIB colon cancer in the Journal of Chemotherapy.
• Researches prognostic biomarkers using PET/CT scans and metabolic tumor volume.
• Treats complex oncological cases at the university-affiliated İstinye University clinic.

Dr. Irfan Cicin is a Professor of Medical Oncology at İstinye University Liv Hospital Topkapı. He specializes in treating complex cancers, including glioblastoma, lung cancer, and pancreatic tumors. He serves as a professor at the Trakya University Faculty of Medicine. Dr. Cicin previously served as a physician in the Turkish Air Force.

• Performs systemic therapies such as immunotherapy, chemotherapy, and hormone therapy.
• Treats a wide range of conditions including gynecologic, orthopedic, and neuro-oncology cases.
• Expert in HIPEC and chemoembolization for liver and abdominal malignancies.
• Works at a 300-bed university hospital with 33 medical departments.

Dr. Mariam Abu Zeid is a clinical oncologist at Shefaa Al Orman International Oncology Hospitals. She is certified by the European Society for Medical Oncology. Dr. Abu Zeid treats solid tumors and hematologic cancers. She holds a Ph.D. in Clinical Oncology and Nuclear Medicine from Ain Shams University.

• Administers chemotherapy, immunotherapy, and targeted treatments for various cancer types.
• Oversees oncology clinical trials and manages treatment-related toxicities.
• Coordinates patient care within multidisciplinary teams for complex staging and diagnosis.
• Practices at an ESMO-accredited center that treats approximately 6,000 patients annually.

Dr. Atakan Topcu is a medical oncologist at Medipol Acibadem District Hospital in Istanbul. He specializes in treating solid tumors including lung, breast, and colorectal cancers. Dr. Topcu is an Associate Professor with over 50 peer-reviewed scientific publications. He sits on the Editorial Board of the medical journal BMC Cancer.

• Expertise in immunotherapy, targeted therapies, and geriatric oncology care.
• Treats cancer-related malnutrition, cachexia, and sarcopenia.
• Maintains active membership in the European Society for Medical Oncology (ESMO).
• Works at a JCI-accredited hospital specializing in advanced oncology treatments.

Doc. dr Nail Paksoy specjalizuje się w leczeniu włókniaków powięziowych (guzów desmoidalnych). Opublikował on badania nad skutecznością sorafenibu w przypadkach objawowych i obecnie pracuje w szpitalu Medipol Bahçelievler.

• Posiada certyfikat ESMO w dziedzinie onkologii klinicznej
• Praca badawcza koncentruje się na mięsakach i nowotworach rzadkich
• Współbadacz w 8 międzynarodowych badaniach klinicznych

Dr. Beni Boursi is a leading oncologist at Sheba Medical Center. He founded the ECOG-ACRIN Microbiome Working Group. He specializes in treating gastrointestinal cancers using innovative microbial modulation. Dr. Boursi is board certified in internal medicine and medical oncology. He earned his medical degree with highest honors from Tel Aviv University.

• Completed oncology fellowships at the University of Pennsylvania.
• Trained in medical oncology at MD Anderson and Mayo Clinic.
• Developed predictive models for early colorectal and pancreatic cancer diagnosis.
• Published research on microbiome-oncology in the prestigious journal Science.

Dr. Maha Yahia is a medical and hemato-oncologist at Shefaa Al Orman International Oncology Hospitals. She served as a Lieutenant Colonel physician in the Egyptian Armed Forces Medical Corps. Dr. Yahia specializes in treatment planning for breast, thoracic, and gastrointestinal cancers. She focuses on immunotherapy, targeted therapy, and complex chemotherapy protocols.

• Former Head of the Clinical Research Support Team at Maadi AFMC.
• Trained at the National Cancer Institute, Cairo University, in hemato-oncology.
• Treats genitourinary, gynecologic, and rare cancers alongside hematologic conditions.
• Works at an ESMO-accredited center that treats 6,000 patients annually.

Dr. Emad Shash is a medical oncologist who has participated in over 70 oncology clinical trials. He serves as the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. Dr. Shash specializes in systemic therapies, including chemotherapy, targeted therapy, and immunotherapy. He holds a Diploma in Hospital Quality Management and Patient Safety from JCI.

• Serves as an ESMO panel voting member and an ASCO committee member.
• Treats breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers.
• Former research physician and medical lead at the EORTC in Brussels.
• Works at Shefaa Al Orman, an ESMO-accredited oncology center treating 6,000 patients annually.

Dr. Raanan Berger is the Director of the Cancer Center at Sheba Medical Center. He was listed in Forbes Israel’s “Best Doctors” in 2025. Dr. Berger specializes in genitourinary oncology and radiates complex prostate tumors. He completed a postdoctoral fellowship at the Dana-Farber/Harvard Cancer Institute.

• Heads the clinical research unit focusing on molecular oncology.
• Co-authored over 20 peer-reviewed papers on prostate cancer and BRCA mutations.
• Member of the American Society of Clinical Oncology (ASCO).
• Performs systemic therapy and radiotherapy at a Top-10 globally ranked hospital.

Dr Volkan Kinas specjalizuje się w chirurgii onkologicznej, w tym w leczeniu włókniaków powięziowych (guzów desmoidalnych), w szpitalach Büyük Anadolu.

• Ekspert w dziedzinie chirurgii onkologicznej, koncentrujący się na złożonych przypadkach
• Wykonuje operacje trzustki i dróg żółciowych wraz z procedurami onkologicznymi
• Specjalizuje się w operacjach raka piersi i tarczycy

Prof. Elke Jaeger jest wybitnym specjalistą w dziedzinie mięsaków oraz Kierownikiem Oddziału Onkologii i Hematologii w Klinice Nordwest.

• Ponad 35 lat doświadczenia w onkologii
• Uznana za jednego z najlepszych onkologów w Niemczech według rankingu Focus
• Specjalizuje się w leczeniu mięsaków